Evidence lacking, cost high for medical cannabis in adult epilepsy

There is a desperate need for randomised trials on the use of medical cannabis in drug-resistant epilepsy in adults,  an expert has told the ANZAN 2018 conference in Darwin. Speaking during a symposium dedicated to medical cannabis Professor Terry O’Brien, Director of Neurology at Alfred Health in Melbourne, noted that much of the hype around ...

Already a member?

Login to keep reading.

© 2021 the limbic